SCHEMBL12746155

SCHEMBL12746155

CC(=O)c1ccc(Cl)c(-c2ccc3c(c2)C(=O)CS3(=O)=O)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ VEGFA P15692 1/20 0.37
▸ EIF4E P06730 2/20 0.35
▸ S100A4 P26447 1/20 0.35
▸ MAPT P10636 5/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ PRKAB2 O43741 1/20 0.34
▸ PRKAG1 P54619 1/20 0.34
▸ PRKAA2 P54646 1/20 0.34
▸ PRKAA1 Q13131 1/20 0.34
▸ PRKAG3 Q9UGI9 1/20 0.34
▸ PRKAG2 Q9UGJ0 1/20 0.34
▸ PRKAB1 Q9Y478 1/20 0.34
▸ HSD17B1 P14061 3/20 0.33
▸ ESR1 P03372 1/20 0.33
▸ ESR2 Q92731 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MAPK14 Q16539 2/20 0.32
▸ MAOB P27338 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12746154 0.82 VEGFA (0.40) VEGFAEIF4ELMNAMAOB
SCHEMBL12746153 0.81 TDP2 (0.47) VEGFA
SCHEMBL12745935 0.78 CA12 (0.52) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL12261826 0.73 VEGFA (0.47) VEGFAMAPTALDH1A1
SCHEMBL12746151 0.73 AHR (0.45) VEGFAS100A4PRKAA1
SCHEMBL21027869 0.73 VEGFA (0.47) VEGFAMAPTSMN1; SMN2LMNAALDH1A1
SCHEMBL10422605 0.70 CA12 (0.58) VEGFAMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL3207912 0.69 TSHR (0.55) EIF4EMAPTPRKAB2PRKAG1PRKAA2
SCHEMBL21032160 0.68 VEGFA (0.50) VEGFAS100A4PRKAA1
Acetic Acid SCHEMBL28517501 0.67 AHR (0.46) MAPTRAB9APRKAB2PRKAG1PRKAA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110071178-A1 Methods and Compounds for Modulating Cannabinoid Activity NORTHEASTERN UNIVERSITY (US) 2011-03-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110071178-A1 Methods and Compounds for Modulating Cannabinoid Activity FAAH, FAAH2, CNR2 VEGFA 4836/4885EIF4E 3863/4885S100A4 3685/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback